| Chaperoning skin atrophy |
|
https://doi.org/10.18632/oncotarget.26375
Donald B. DeFranco
|
| 36407-36408 |
p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1
p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1 |
|
https://doi.org/10.18632/oncotarget.26376
Katerina Cerna,
and Marek Mraz
|
| 36409-36410 |
Epstein-Barr virus: From kisses to cancer, an ingenious immune evader
Epstein-Barr virus: From kisses to cancer, an ingenious immune evader |
|
https://doi.org/10.18632/oncotarget.26381
Pankaj Trivedi,
Frank J. Slack,
and Eleni Anastasiadou
|
| 36411-36412 |
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation |
|
https://doi.org/10.18632/oncotarget.26326
Kathleen I. Pishas,
and Stephen L. Lessnick
|
| 36413-36429 |
Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis
Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis |
|
https://doi.org/10.18632/oncotarget.26335
Kirsty R. Greenow,
Matthew Zverev,
Stephanie May,
Howard Kendrick,
Geraint T. Williams,
Toby Phesse,
and Lee Parry
|
| 36430-36443 |
Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer
Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer |
|
https://doi.org/10.18632/oncotarget.26342
Giovanny Rodríguez-Blanco,
Lona Zeneyedpour,
Diederick Duijvesz,
A. Marije Hoogland,
Esther I. Verhoef,
Charlotte F. Kweldam,
Peter C. Burgers,
Peter Sillevis Smitt,
Chris H. Bangma,
Guido Jenster,
Geert J.L.H. van Leenders,
Lennard J.M. Dekker,
and Theo M. Luider
|
| 36444-36456 |
Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression
Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression |
|
https://doi.org/10.18632/oncotarget.26355
Marie Simonneau,
Eric Frouin,
Vincent Huguier,
Cynthia Jermidi,
Jean François Jégou,
Julie Godet,
Anne Barra,
Isabelle Paris,
Pierre Levillain,
Sevda Cordier-Dirikoc,
Nathalie Pedretti,
François Xavier Bernard,
Jean Claude Lecron,
Franck Morel,
and Laure Favot
|
| 36457-36473 |
Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells
Distinct mechanisms by which two forms of miR-140 suppress the malignant properties of lung cancer cells |
|
https://doi.org/10.18632/oncotarget.26356
Valentina Flamini,
Ed Dudley,
Wen G. Jiang,
and Yuxin Cui
|
| 36474-36491 |
Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer
Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer |
|
https://doi.org/10.18632/oncotarget.26362
Neelam Mukherjee,
Niannian Ji,
Vincent Hurez,
Tyler J. Curiel,
Maureen O. Montgomery,
Andrew J. Braun,
Marlo Nicolas,
Marcela Aguilera,
Dharam Kaushik,
Qianqian Liu,
Jianhua Ruan,
Kerri A. Kendrick,
and Robert S. Svatek
|
| 36492-36502 |
Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma
Establishment of a novel cell line from a rare human duodenal poorly differentiated neuroendocrine carcinoma |
|
https://doi.org/10.18632/oncotarget.26367
Kazuyoshi Yanagihara,
Takanori Kubo,
Keichiro Mihara,
Takeshi Kuwata,
Atsushi Ochiai,
Toshio Seyama,
and Hiroshi Yokozaki
|
| 36503-36514 |
Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells
Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells |
|
https://doi.org/10.18632/oncotarget.26369
Shoma Tamori,
Yuka Nozaki,
Hitomi Motomura,
Hiromi Nakane,
Reika Katayama,
Chotaro Onaga,
Eriko Kikuchi,
Nami Shimada,
Yuhei Suzuki,
Mei Noike,
Yasushi Hara,
Keiko Sato,
Tsugumichi Sato,
Kouji Yamamoto,
Takehisa Hanawa,
Misa Imai,
Ryo Abe,
Atsushi Yoshimori,
Ryoko Takasawa,
Sei-Ichi Tanuma,
and Kazunori Akimoto
|
| 36515-36529 |
Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma
Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma |
|
https://doi.org/10.18632/oncotarget.26370
Hazel Anne Rogers,
Rebecca Chapman,
Holly Kings,
Julie Allard,
Jodie Barron-Hastings,
Kristian W. Pajtler,
Martin Sill,
Stefan Pfister,
and Richard Guy Grundy
|
| 36530-36541 |
Correction: Se2Mo10V3, a heteropoly compound containing selenium, inhibits tumor growth
Correction: Se2Mo10V3, a heteropoly compound containing selenium, inhibits tumor growth |
|
https://doi.org/10.18632/oncotarget.26408
Hong-Ning Zhang,
Wei-Li Feng,
Chun-Na An,
and Wen-Guang Li
|
| 36542-36542 |
